Gerald Preston

Array ( [id] => 4010800 [patent_doc_number] => 05879895 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Recombinant bovine herpesvirus type 1 polypeptides and immunoassays' [patent_app_type] => 1 [patent_app_number] => 8/695480 [patent_app_country] => US [patent_app_date] => 1996-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 63 [patent_no_of_words] => 37180 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/879/05879895.pdf [firstpage_image] =>[orig_patent_app_number] => 695480 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4002843 [patent_doc_number] => 05858989 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Vaccines comprising nucleotide sequences encoding bovine herpesvirus type 1 g1, g111 and gIV' [patent_app_type] => 1 [patent_app_number] => 8/682847 [patent_app_country] => US [patent_app_date] => 1996-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 50 [patent_figures_cnt] => 62 [patent_no_of_words] => 38154 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858989.pdf [firstpage_image] =>[orig_patent_app_number] => 682847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4070057 [patent_doc_number] => 06069001 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Isolated, truncated nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/602039 [patent_app_country] => US [patent_app_date] => 1996-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 8616 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/069/06069001.pdf [firstpage_image] =>[orig_patent_app_number] => 602039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4186608 [patent_doc_number] => 06042837 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-28 [patent_title] => 'Methods of staphylococcal enterotoxin directed cell-mediated cytotoxicity (SDCC)' [patent_app_type] => 1 [patent_app_number] => 8/596555 [patent_app_country] => US [patent_app_date] => 1996-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 2 [patent_no_of_words] => 2677 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/042/06042837.pdf [firstpage_image] =>[orig_patent_app_number] => 596555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3661826 [patent_doc_number] => 05597563 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-28 [patent_title] => 'Method induction of antigen-specific immune tolerance' [patent_app_type] => 1 [patent_app_number] => 8/573648 [patent_app_country] => US [patent_app_date] => 1995-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10016 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/597/05597563.pdf [firstpage_image] =>[orig_patent_app_number] => 573648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764034 [patent_doc_number] => 05849306 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Binding domains from Plasmodium vivax and Plasmodium falciparum erythrocyte binding proteins' [patent_app_type] => 1 [patent_app_number] => 8/568459 [patent_app_country] => US [patent_app_date] => 1995-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13786 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849306.pdf [firstpage_image] =>[orig_patent_app_number] => 568459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770402 [patent_doc_number] => 05817315 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-06 [patent_title] => 'Recombinant vaccine' [patent_app_type] => 1 [patent_app_number] => 8/561151 [patent_app_country] => US [patent_app_date] => 1995-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3067 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/817/05817315.pdf [firstpage_image] =>[orig_patent_app_number] => 561151 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3998401 [patent_doc_number] => 05858689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Isolated peptides derived from the gage tumor rejection antigen precursor and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/531662 [patent_app_country] => US [patent_app_date] => 1995-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 9651 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858689.pdf [firstpage_image] =>[orig_patent_app_number] => 531662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771928 [patent_doc_number] => 05734023 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'MHC class II .beta. chain/peptide complexes useful in ameliorating deleterious immune responses' [patent_app_type] => 1 [patent_app_number] => 8/483021 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 29 [patent_no_of_words] => 19756 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/734/05734023.pdf [firstpage_image] =>[orig_patent_app_number] => 483021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4254504 [patent_doc_number] => 06207815 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-27 [patent_title] => 'Family of high affinity, modified antibodies for cancer treatment' [patent_app_type] => 1 [patent_app_number] => 8/479285 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 62 [patent_figures_cnt] => 46 [patent_no_of_words] => 33995 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/207/06207815.pdf [firstpage_image] =>[orig_patent_app_number] => 479285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3996212 [patent_doc_number] => 05919910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Monoclonal antibodies' [patent_app_type] => 1 [patent_app_number] => 8/477553 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 14 [patent_no_of_words] => 5435 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919910.pdf [firstpage_image] =>[orig_patent_app_number] => 477553 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3942235 [patent_doc_number] => 05976845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-02 [patent_title] => 'Composite antibodies of human subgroup IV light chain capable of binding to TAG-72' [patent_app_type] => 1 [patent_app_number] => 8/487743 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 64 [patent_figures_cnt] => 31 [patent_no_of_words] => 19736 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/976/05976845.pdf [firstpage_image] =>[orig_patent_app_number] => 487743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3879064 [patent_doc_number] => 05776459 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-07 [patent_title] => 'TCR V beta 5 peptides' [patent_app_type] => 1 [patent_app_number] => 8/476405 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8516 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/776/05776459.pdf [firstpage_image] =>[orig_patent_app_number] => 476405 [rel_patent_id] =>[rel_patent_doc_number] =>)